Taiwan Semiconductor Manufacturing Company Limited
TSM
买入
2026年10月23日Neutral
决策摘要
TSM closed at $418.51 on October 23, 2026, up 1.49% from $412.35, but the rebound came on only 9.45 million shares - 0.83x the 20-day average of 11.37 million and 0.85x the 60-day average of 11.13 million - so the session produced a constructive candle without institutional confirmation. The shape of that candle matters: the stock undercut the October 19 and October 20 lows of $415.50 and $416.12 intraday, printed a low of $411.15 (a marginal higher low versus the October 22 low of $410.22), then closed at 92% of the day's $411.15-$421.31 range, leaving it only $11.38 above the October 15 earnings-day low of $407.13. Macro turned slightly more hostile in level terms but less hostile in composition: the rose 2.21% to 19.45, still inside the 15-20 Neutral band but only 0.55 points from the Risk-Off threshold, the 10-year Treasury yield backed up 3.5 basis points to 4.988%, and yet the Nasdaq fell just 0.21% while the Dow dropped 1.23% and the S&P 500 lost 0.52% - a reversal of the October 22 AI-specific unwind that had hit TSM for -4.53%. Fundamentals are unchanged and still improving: FY27 consensus sits at $23.38529 versus $22.29861 seven days ago (+4.87%) and $21.28402 ninety days ago (+9.87%), FY26 at $17.50426 versus $17.03445 (+2.76%), with zero downward revisions in any period over the trailing 30 days, a 6 Strong Buy / 14 Buy / 1 Hold rating mix and zero downgrades in 90 days. Valuation remains the strongest part of the bull case at 17.90x the FY27 consensus and 27.12x trailing earnings of roughly $15.43 against 50.9% revenue growth, 68.7% earnings growth and a 0.858 , while the $440 low analyst target sits 5.1% above spot and the $557.50 median implies 33.2% upside. Technicals improved at the margin but not in structure: (14) rebounded to 41.46 from 38.02, the histogram narrowed to -4.818 from -5.315, and recovered to 90.96 million from 81.51 million, yet the line made a new series low at -5.946 with the signal crossing below zero to -1.127, price is 3.56% below the 50-day of $433.95 and 6.08% below the 20-day of $445.60, and remains 41.4% below its October 5 peak of 155.26 million. The news pool is still dated September 29 and predates the October 15 print, so the freshest usable catalysts are the revision feed - Barclays to $670 from $665, DA Davidson maintaining Buy with $500, Needham to $560 from $530 - plus the October 15-23 price action. Next earnings is January 14, 2027, 82 days out, so no scheduled binary event sits inside the 30-day window. I keep the overall rating at BUY with the score nudged to 71 from 70, upgrade the one-month view to HOLD from SELL on the reversal candle and the light-volume stabilization, and keep BUY for six months and STRONG BUY for one year. The line that still matters most is $407.13; a close below it opens the 200-day at $389.85.
投资判断
实时价格
$424.37
推荐分数
71%
71%
置信度
63%
63%
各期限展望
1个月
持有
短线
6个月
买入
中期
1年
强力买入
长期
核心催化
The October 22-23 two-session sequence is the single most market-moving item: TSM gave back the entire three-session post-earnings rebound with a 4.53% decline to $412.35 on 16.48 million shares (1.45x average), then reversed intraday on October 23 off a $411.15 low to close at $418.51 on light 9.45 million volume while the Nasdaq outperformed the Dow by more than a full percentage point - a failed bounce followed by a low-volume stabilization, with the next real test at the $407.13 October 15 low. Note that the article pool in this bundle is dated September 29 and predates the October 15 print by more than two weeks, so the freshest usable catalysts are the analyst actions in the revision feed and the October 15-23 price action rather than the article content.
Hold roughly half of normal weight and avoid leverage. The regime is still classified Neutral on a 19.45 , but the level is only 0.55 points from the Risk-Off threshold, 20-day realized volatility is 32.61%, the is 3.06% of price, and the intermediate trend remains broken with price 3.56% below the 50-day . The October 23 reversal candle justifies holding rather than cutting further, but the 0.83x volume means it does not yet justify adding. Rebuild toward full weight only on a daily close above $435.16 with above-average volume, or on a retest of $407.13 that holds on declining volume; a daily close below $407.13 should reduce exposure further toward the $389.85 200-day rather than averaging down. The unresolved conflict is explicit: fundamentals (17.90x forward, 0.858 , zero downward revisions, 33.2% median analyst upside) argue for owning it, while the tape ( line at a series low of -5.946 with the signal below zero at -1.127, 41.4% below its October 5 peak, price below both the 20-day and 50-day ) argues for patience.
投资逻辑快照
什么情况涨
The strongest bull case is that fundamentals are accelerating into a falling price for the third time in three months, and that asymmetry rarely persists: FY27 consensus sits at $23.38529 versus $22.29861 a week ago (+4.87%) and $21.28402 ninety days ago (+9.87%), FY26 at $17.50426 versus $17.03445 (+2.76%), the current quarter at $5.1641 versus $5.04936, with zero downward revisions in any period over 30 days and a rating mix of 6 Strong Buy, 14 Buy and a single Hold that improved from 6/12/1 two months ago with zero downgrades in 90 days. At $418.51 the stock trades at 17.90x FY27 earnings and 27.12x trailing with a 0.858 against 50.9% revenue growth and 68.7% earnings growth, and the sell-side gap has widened further: the LOWEST published target of $440 is now 5.1% above spot while the $584.39 mean implies 39.6% upside, and analysts kept raising through both drawdowns - Barclays to $670, DA Davidson maintaining $500, Needham to $560, Stifel initiating at $515. The franchise is unharmed at nearly 73% foundry share, a 65.85% gross margin, a 41.85% and seven consecutive beats, the > > golden-cross stack is still intact with price 7.35% above the $389.85 200-day , and the October 23 session printed a reversal candle off $411.15 that closed at 92% of the daily range while the Nasdaq outperformed the Dow by more than a full percentage point - the first evidence in six sessions that the AI-specific liquidation is losing force. Prior published targets also earned partial validation: the $396-$412 entry zone was tagged on October 23 at $411.15, giving patient buyers the intended fill.
什么情况跌
The strongest argument against owning TSM here is that the October 23 bounce was a low-quality reflex off support, not a repair: it ran on 9.45 million shares, 0.83x the 20-day average and the lightest full session since October 13, immediately after a 16.48 million-share (1.45x) distribution day - so the up-day/down-day volume asymmetry that defines institutional selling has not been broken. Price remains 3.56% below the falling 50-day at $433.95 and 6.08% below the 20-day at $445.60, the intraday action still undercut the October 19 and October 20 lows of $415.50 and $416.12 before recovering, and the close left the stock just $11.38 above the October 15 earnings low of $407.13. The momentum deterioration is severe: the line printed a fresh series low at -5.946 and the signal crossed below zero to -1.127, at 41.46 is still in bearish territory below 50, and at 90.96 million sits 41.4% below the October 5 peak of 155.26 million. The fundamental cushion is thinner than it looks: the September quarter beat by only 1.67% versus a 6.29% seven-quarter average, sequential growth decelerated to +6.73% from +23.5%, and the market has now sold the same good print twice. A credible short thesis is that AI demand normalizes while N2 yields, advanced-packaging utilization and returns on the roughly $29.44B capacity approval plus the $100B Arizona program disappoint, compressing margins and the multiple from a 27.12x trailing base, with HBM, hybrid-bonding, glass-substrate and cooling suppliers absorbing a growing share of value-chain economics. Macro is not helping: the at 19.45 is 0.55 points from Risk-Off, the 10-year yield backed up 3.5bp to 4.988%, the GF Value of $363.95 sits 13.0% below spot so there is no model floor, the feed's EV, cash and FCF aggregates cannot be reconciled to the $2.17T market cap, and short interest at just 0.63% of float on a 3.14 short ratio means there is no squeeze fuel to cushion a break lower. Taiwan concentration remains a permanent tail risk that can gap the ADR independently of results, and the article pool in this bundle is three-plus weeks stale and predates the print entirely.
A daily close below $407.13 - the October 15 earnings-day low - would confirm that the latest stabilization attempt has failed and reopen the 200-day at $389.85; a subsequent close below $378 would break the multi-year uptrend structure itself and should trigger a full exit regardless of the long-term franchise view. Conversely, the cautious near-term stance is invalidated by a daily close above $435.16 (the October 21 rejection high and the 50-day ) on above-average volume, which would re-establish the higher-low structure and restore the constructive six-month setup with $445.60 as the next objective.
Post-earnings de-rating risk is no longer theoretical: the September quarter beat by only 1.67% versus a 6.29% seven-quarter average, sequential growth decelerated to +6.73% from +23.5%, and the ADR at $418.51 is still 2.67% below its $430.00 pre-print close and 14.15% below its $487.47 high, so the market is pricing a materially higher bar into the January 14, 2027 guidance cycle 82 days away.
Technical distribution has not been reversed: TSM closed October 22 at -4.53% on 1.45x average volume, the October 23 bounce came on 0.83x average volume, price sits 3.56% below the 50-day of $433.95 and 6.08% below the 20-day of $445.60, the line printed a fresh series low at -5.946 with the signal at -1.127, and at 90.96 million remains 41.4% below the 155.26 million October 5 peak.
AI-complex contagion and volatility risk: the at 19.45 is only 0.55 points below the Risk-Off threshold and 20-day realized volatility is 32.61%, so another leg higher in volatility would extend de-risking in high-multiple AI leaders regardless of company results - while a further rise in the 10-year yield from 4.988% back toward the 5.146% October 21 level would re-apply multiple pressure on a 27.12x trailing base.
Execution and capital-intensity risk: N2 ramp yields, advanced-packaging utilization and returns on the roughly $29.44B capacity approval plus the $100B Arizona program may undershoot, exposing substantial fixed-cost operating leverage while HBM, hybrid-bonding, glass-substrate and cooling specialists capture a larger share of AI value-chain economics, and incremental 2nm capacity remains unconfirmed on timing, size and node.
Geopolitical and data-integrity risk: essentially all leading-edge capacity is concentrated in Taiwan, creating cross-strait tail risk that no fundamental model captures and no stop can protect against on a gap, while the feed's $14.17T enterprise value, $4.017T cash, 0.439x price-to-sales, 3.92x and 55.43% FCF yield mix TWD-denominated statement values with a USD market cap and cannot serve as a valuation backstop.
接下来关注
下一次财报：2027年1月14日
The October 22-23 two-session sequence is the single most market-moving item: TSM gave back the entire three-session post-earnings rebound with a 4.53% decline to $412.35 on 16.48 million shares (1.45x average), then reversed intraday on October 23 off a $411.15 low to close at $418.51 on light 9.45 million volume while the Nasdaq outperformed the Dow by more than a full percentage point - a failed bounce followed by a low-volume stabilization, with the next real test at the $407.13 October 15 low. Note that the article pool in this bundle is dated September 29 and predates the October 15 print by more than two weeks, so the freshest usable catalysts are the analyst actions in the revision feed and the October 15-23 price action rather than the article content.
信号仪表盘
决策输入
6 个信号
基本面
39.6%
距分析师均值目标空间
At $418.51 TSM trades at 27.12x trailing earnings (roughly $15.43 of trailing derived from the $3.14, $3.49, $4.31 and $4.60 quarters) and 17.90x the FY27 consensus of $23.38529, against a 0.858 , 50.9% revenue growth and 68.7% earnings growth. The Zacks comparison in the supplied September 29 coverage posted 22.51x forward-12-month at $457.175 versus a 24.21x historical median; scaling for the 8.5% decline to $418.51 implies roughly 20.6x, and the gap versus the feed's 17.90x is a basis difference (blended forward-12-month versus full FY27), with both readings below the 24.21x median. On the feed's own FY27 number, 17.90x for roughly 34% forward growth is a growth-adjusted multiple near 0.5x, comfortably cheap on a basis even before the 0.858 three-to-five-year measure is applied. The feed's price-to-book of 79.87x and price-to-sales of 0.439x are not usable as value arguments: the sales, cash, debt, cash-flow and enterprise-value fields appear to be TWD-denominated statement values reported alongside a USD market cap, which is why the 'FCF yield' prints an impossible 55.43% and the enterprise value of $14.17T runs at 6.53x the $2.17T market cap. The stale $363.95 GF Value from the September 29 coverage now sits 13.0% below the $418.51 close, so there is no dependable model-based floor. Net: fair value to modestly cheap on a growth-adjusted basis, with the October selloff having improved the entry arithmetic versus the $487.47 high, but not a deep-value margin of safety.
技术面
Bearish
趋势质量
TSM closed at $418.51, about 6.08% below the 20-day of $445.60 and 3.56% below the 50-day of $433.95, but still 7.35% above the 200-day of $389.85. The ($445.60) > ($433.95) > ($389.85) golden-cross stack remains intact, so the long-term bull market is unbroken even as the intermediate trend stays broken after the October 22 failure. The October 23 session was the first genuinely constructive tape in six sessions: price undercut the October 19 and October 20 lows of $415.50 and $416.12 with a $411.15 intraday print, then reversed to close at $418.51 - 92% of the $411.15-$421.31 daily range - and posted a marginally higher low versus October 22's $410.22. That is a short-term stabilization candle, not a repair: the stock still sits $11.38 above the October 15 earnings-day low of $407.13, the October 21 rejection at $435.16 remains $16.65 overhead, and the 50-day at $433.95 is still falling. The stock is 14.15% below the $487.47 52-week high, 56.85% above the $266.82 low and at the 68.75% mark of its 52-week range: a confirming intermediate downtrend inside an intact long-term uptrend, with $389.85 as the line that separates repair from regime change.
财报
82天
Improving
The September 2026 quarter, reported October 15, delivered of $4.60 against a $4.52449 estimate, a beat of only 1.67%, the narrowest of the seven supplied quarters and well below the 6.29% average surprise; the ADR gapped from $430.00 to an intraday low of $407.13 before closing at $422.25 (-1.80%) on 22.45 million shares, slid to $412.61 (-2.28%) on October 16, recovered through $420.22, $425.08 and $431.89 into October 21, gave the entire rebound back on October 22 with a 4.53% decline to $412.35 on 16.48 million shares, and then reversed intraday on October 23 with a $411.15 low and a $418.51 close (+1.49%) on light 9.45 million volume - leaving the stock 2.67% below its $430.00 pre-print close despite a 57.5% year-over-year increase; the December-quarter consensus has nevertheless been revised UP to $5.1641 and the market's focus is squarely on N2 ramp margins and January guidance rather than the headline number.
新闻
Mixed-Bearish
新闻基调
The October 22-23 two-session sequence is the single most market-moving item: TSM gave back the entire three-session post-earnings rebound with a 4.53% decline to $412.35 on 16.48 million shares (1.45x average), then reversed intraday on October 23 off a $411.15 low to close at $418.51 on light 9.45 million volume while the Nasdaq outperformed the Dow by more than a full percentage point - a failed bounce followed by a low-volume stabilization, with the next real test at the $407.13 October 15 low. Note that the article pool in this bundle is dated September 29 and predates the October 15 print by more than two weeks, so the freshest usable catalysts are the analyst actions in the revision feed and the October 15-23 price action rather than the article content.
宏观
Neutral
4.99% 10Y / 19.5 VIX
at 19.45 sits 0.55 points below the Risk-Off threshold after a 2.21% rise, and the October 23 tape (Nasdaq -0.21% versus Dow -1.23% and S&P 500 -0.52%) shows the AI-multiple liquidation of October 22 has paused without reversing, which supports holding but not enlarging a 1.239-beta, 32.61%-realized-volatility position; the offset is a 10-year Treasury yield that is still 41 basis points below the 5.146% level of October 21, keeping multiple-compression pressure on the 27.12x trailing base contained for now.
稳定性
High-Beta Growth
Core Growth
TSM is a franchise-grade High- Growth asset rather than a speculative one: supplied coverage cites nearly 73% of the global foundry market in Q2 2026 versus 4% for UMC, and the feed shows a 65.85% gross margin, a 58.65% operating margin, a 73.04% margin, a 41.85% , a 2.51 current ratio, a 4.91x cash-to-debt ratio and seven consecutive supplied beats with zero downward revisions in any period over the trailing 30 days. Its Core Growth role is earned by the leading-edge technology position, the A14 roadmap running ahead of schedule, and FY27 consensus of $23.38529 versus $21.28402 ninety days ago. The risk being underwritten is real and was reasserted twice this month: a 1.239 beta, 32.61% 20-day realized volatility, an of 3.06% of price, essentially all leading-edge capacity concentrated in Taiwan, a 4.53% single-day decline on October 22, and a line that printed a fresh series low of -5.946 on October 23. With the shares 14.15% below the $487.47 high and 3.56% below the 50-day of $433.95, investors should expect recurring mid-teens drawdowns around earnings, AI-tape unwinds and macro shocks even with the multi-year franchise thesis intact.
分析师目标区间
均值目标
$584.39
高低目标
$440 / $1000
分析师中值目标
$557.50
共识区间
$440 - $1000
— 位分析师
Mean
$440$584$1000
市场共识
The $584.39 mean target implies 39.6% upside from $418.51 and the $557.50 median implies 33.2%, while the $440 low target sits 5.1% ABOVE spot - an unusual configuration in which even the most cautious published analyst is above the market price, consistent with targets lagging the selloff rather than signalling a fundamental gap-down. The $1000 high target implies 138.9% upside and the roughly $560 spread between low and high is genuine disagreement about the durability of the AI capacity cycle and the appropriate multiple; the number-of-analysts field is null, but the summary mix of 6 Strong Buy, 14 Buy and 1 Hold implies roughly 21 covering analysts, adequate breadth rather than thin coverage. The direction of travel matters more than the level: targets were raised at Barclays, Needham and Stifel within the last seven weeks with zero downgrades in 90 days, a materially better posture than the October 22-23 price action implies.
筹码脉冲
内部人信号
Neutral
净偏向
Balanced
内部人持股
0.0%
机构持股
15.5%
解读
Total disclosed value of roughly $346,000 is immaterial against a $2.17T market cap and transaction direction is unverifiable, so insider activity provides no actionable signal and should neither offset nor reinforce the fundamental case.
重要活动
Five supplied records: Director Ursula M. Burns with 1,000 shares valued at $322,050, and Officer Bor-Zen Tien with 20, 17, 10 and 15 shares worth roughly $24,378 in aggregate across four filings ranging from $4,050 to $7,760. Transaction-type fields are blank and the dates are ordinal placeholders (0-4) rather than dates, and no sale rows appear, so direction cannot be confirmed from the feed.
市场背景
行业
Semiconductors
Mixed-Bullish
情绪
24
跟踪股票
13
分组
industry
Semiconductors 行业 当前情绪为 Mixed-Bullish，板块平均评分约 53 分，资金与评分正在同步走强，且leadership is concentrated in NVDA, AVGO, MU。
TSM is the foundry bottleneck for AI accelerators and custom silicon, and the September 29 coverage names Apple, Nvidia, AMD, Qualcomm, Google, Broadcom, Marvell, Amazon and OpenAI as advanced-node customers while JPMorgan argued the pullback made semiconductor valuations more attractive. The structural case keeps being reinforced by earnings revisions - FY27 consensus at $23.38529 versus $22.29861 a week ago and $21.28402 ninety days ago with zero downward revisions - but the equity expression remains in de-rating mode: TSM is still 14.15% below its $487.47 high, 3.56% below its 50-day of $433.95, and at 90.96 million sits 41.4% below its October 5 peak even after the October 23 recovery. The theme is intact at the earnings level and hostile at the multiple level, which is exactly the tug-of-war the current price reflects.
The October 22 AI-multiple unwind and the October 23 partial stabilization - Nasdaq -0.21% against Dow -1.23% - is the immediate driver, and with the back at 19.45 and no company catalyst until January 14, the theme's near-term direction is being set by positioning flows rather than by demand data.
Capital behavior in the AI complex flipped twice in two sessions: the Nasdaq fell 2.60% on October 22 with the Dow flat while TSM fell 4.53%, then on October 23 the Nasdaq fell only 0.21% while the Dow dropped 1.23% and TSM rose 1.49% - high-beta AI liquidation pausing rather than reversing.
Analysts kept raising targets through the drawdown - Barclays to $670, DA Davidson maintaining $500, Needham to $560, Stifel initiating at $515 - while FY27 estimates moved from $21.28402 ninety days ago to $23.38529, confirming the earnings case strengthens even as the multiple compresses.
The rate backdrop is a partial counterweight: the 10-year Treasury yield at 4.988% remains 41 basis points below the 5.146% reached on October 21, which mechanically supports long-duration AI multiples even after the 3.5bp back-up on October 23.
Leading-Edge Foundry and Advanced Packaging (N2/A14/CoWoS)
评分: 35
Mixed-Bullish
TSM is the direct listed leader in leading-edge foundry, with supplied coverage citing nearly 73% market share, broad N2 customer demand, A14 tape-outs ahead of schedule, and roughly $29.44B of approved capacity and advanced-packaging spending plus a $100B Arizona program and three N3 fabs across Taiwan, Arizona and Japan. The theme is structurally strengthening - Wells Fargo's report of a potential incremental 2nm expansion is read as an incremental positive for the whole equipment chain - but the economics only accrue if ramp yields and packaging utilization support returns, and the coverage explicitly notes HBM, hybrid bonding, glass-substrate and cooling specialists may capture a larger share of AI value-chain economics. The stock is 14.15% below its $487.47 high and 3.56% below its 50-day at $433.95, showing participants are reassessing execution and valuation risk rather than abandoning the theme.
Post-earnings digestion of N2 ramp costs, the unconfirmed incremental 2nm capacity report, and the October 22 failure followed by the October 23 reversal off $411.15 are the immediate swing factors for both TSM and the semiconductor equipment chain.
The roughly $29.44B capacity and advanced-packaging approval, three N3 fabs across Taiwan, Arizona and Japan, conversion of 5nm tools to N3, and the ASML collaboration on larger-format EUV photomasks reinforce a multi-year leading-edge capex cycle across equipment and materials suppliers.
A14 pre-production is slated for 2027 and volume production for 2028 with tape-outs ahead of schedule, but N2 margin dilution and unconfirmed incremental 2nm plans temper the near-term payoff, and the absence of volume on the October 23 bounce (0.83x the 20-day average) is a live counter-signal.
关键指标
23 项指标
市值
$2.17T
市盈率 (TTM)
27.1
远期市盈率
17.9
营收增速
50.9%
净资产收益率
41.9%
Beta 系数
1.24
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
0.4
市净率
79.9
企业价值 / EBITDA
3.9
质量与资产负债表
利润率、杠杆与流动性。
毛利率
65.8%
营业利润率
58.7%
资产负债率
11.6
流动比率
2.51x
速动比率
2.29x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
0.6%
空头回补天数
3.14x
52周最高
$487.47
52周最低
$266.82
距52周高点
-14.1%
距52周低点
56.8%
公司分类
板块与行业背景。
板块
Technology
行业
Semiconductors
其他信号
自由现金流
$1203071877120.00
详细分析
估值
At $418.51 TSM trades at 27.12x trailing earnings (roughly $15.43 of trailing derived from the $3.14, $3.49, $4.31 and $4.60 quarters) and 17.90x the FY27 consensus of $23.38529, against a 0.858 , 50.9% revenue growth and 68.7% earnings growth. The Zacks comparison in the supplied September 29 coverage posted 22.51x forward-12-month at $457.175 versus a 24.21x historical median; scaling for the 8.5% decline to $418.51 implies roughly 20.6x, and the gap versus the feed's 17.90x is a basis difference (blended forward-12-month versus full FY27), with both readings below the 24.21x median. On the feed's own FY27 number, 17.90x for roughly 34% forward growth is a growth-adjusted multiple near 0.5x, comfortably cheap on a basis even before the 0.858 three-to-five-year measure is applied. The feed's price-to-book of 79.87x and price-to-sales of 0.439x are not usable as value arguments: the sales, cash, debt, cash-flow and enterprise-value fields appear to be TWD-denominated statement values reported alongside a USD market cap, which is why the 'FCF yield' prints an impossible 55.43% and the enterprise value of $14.17T runs at 6.53x the $2.17T market cap. The stale $363.95 GF Value from the September 29 coverage now sits 13.0% below the $418.51 close, so there is no dependable model-based floor. Net: fair value to modestly cheap on a growth-adjusted basis, with the October selloff having improved the entry arithmetic versus the $487.47 high, but not a deep-value margin of safety.
资产负债表
The reported 11.62 debt-to-equity figure reads as percentage-scaled (11.62%) rather than 11.6x levered, and it is corroborated by a 4.91x cash-to-debt ratio, a 3.82x operating-cash-flow-to-debt ratio, a 2.51 current ratio and a 2.29 quick ratio - all consistent with a cash-generative, investment-grade balance sheet that is nowhere near the binding constraint on this thesis. The feed's $4.017T total cash against $0.818T total debt is directionally a large net-cash position, and the derived net-cash-to-market-cap ratio of 147.36% is magnitude-contaminated by the currency mismatch, but the ratio evidence is internally consistent and reliable even when the absolute values are not. A 41.85% paired with a 20.58% confirms returns are generated by operating excellence rather than leverage, and the balance sheet can fund the Arizona and N2 build without straining liquidity.
增长
Revenue growth of 50.9% and earnings growth of 68.7% remain exceptional for a company of this size. Supplied quarterly has climbed without interruption from $2.12 (March 2025) through $2.47, $2.92, $3.14, $3.49 and $4.31 to $4.60, a 57.5% year-over-year increase in the September 2026 quarter, but sequential growth decelerated to +6.73% from +23.5% in the June 2026 quarter. Consensus models FY26 of $17.50426 (roughly +64% versus the $10.65 sum of the four 2025 quarters as supplied) and FY27 of $23.38529 (roughly +34% year over year), and both have been revised up with FY27 up 4.87% in seven days and 9.87% in ninety days. Management expects leading-edge demand plus cost improvements to offset the steep N2 ramp, but the 1.67% September surprise was the narrowest of the seven supplied quarters, showing consensus has largely caught up to that ramp and the burden of proof now sits on January guidance.
生意质量
Leading-edge foundry is one of the highest-barrier businesses in the global economy and TSM's numbers reflect it: a 65.85% gross margin, a 58.65% operating margin, a 73.04% margin and a 51.12% net margin, with of 41.85% and of 20.58%. Supplied coverage cites nearly 73% of the global foundry market in Q2 2026 versus 4% for UMC, and current and quick ratios of 2.51 and 2.29 provide a genuine liquidity buffer. Insider ownership of about 0.01% and institutional ownership of 15.51% reflect the ADR structure rather than a governance flaw. The two quality caveats are concentration of revenue in a handful of leading-edge customers (Apple, Nvidia, AMD, Qualcomm, Google, Broadcom, Marvell, Amazon and OpenAI are all named in the supplied coverage) and the fact that essentially all leading-edge capacity sits in Taiwan, which is a permanent structural discount no margin line offsets.
资本配置
Management is deploying aggressively: roughly $29.44B approved for capacity, advanced packaging and construction, an additional $100B Arizona program, three N3 fabs across Taiwan, Arizona and Japan, conversion of 5nm tools to N3 in Taiwan, and an ASML collaboration on larger-format EUV photomasks intended to raise fab productivity, cut cost per die and remove stitching constraints. These commitments defend the technology lead and add geographic redundancy but raise fixed-cost operating leverage if demand, yields or packaging utilization disappoint, and the supplied coverage notes that HBM, hybrid-bonding, glass-substrate and advanced-cooling specialists may capture a growing share of AI value-chain economics. The feed lists 5.186B shares outstanding, a 0.91% dividend yield and a 24.46% payout ratio, but provides no share-count history or buyback data, so dilution cannot be assessed; with the cash-flow fields currency-contaminated, the exact degree of internal funding of the capex program also cannot be confirmed from this bundle.
预期修正
Revision momentum remains uniformly positive through a second consecutive drawdown, confirming rather than newly accelerating: over the last 30 days there were zero downward revisions in any of the four periods and 2-3 upward revisions in each, with FY26 at $17.50426 (7 days ago $17.03445, +2.76%; 30 days ago $16.92658; 90 days ago $16.69542, +4.85%) and FY27 at $23.38529 (7 days ago $22.29861, +4.87%; 30 days ago $21.91887; 90 days ago $21.28402, +9.87%). The current-quarter estimate sits at $5.1641 versus $5.04936 seven days ago and $4.9585 ninety days ago (+4.15%), and next-quarter at $5.19402 versus $5.05694 (+2.71%) and $4.89148 ninety days ago (+6.18%). Sell-side actions confirm the direction: Barclays raised its target to $670 from $665 on October 16, DA Davidson maintained Buy with a $500 target the same day, Needham raised to $560 from $530 on October 15, and Barclays had already moved to $665 from $650 on October 6 after Stifel initiated at Buy with $515 on September 2, with zero downgrades recorded in the last 90 days and the rating mix improving to 6 Strong Buy / 14 Buy / 1 Hold from 6/12/1 two months ago. The caveat is that the September-quarter beat was only 1.67% against a 6.29% seven-quarter average, so the bar into the January 14 print is measurably higher even as the estimates keep climbing.